Dentium (A145720) Q1 2025 earnings summary

Executive summary

• Maintains a leading position in dental medical devices, focusing on digital dentistry and implant systems.

• Operates a robust domestic and international network, supporting global expansion.

• Q1 2025 revenue was ₩64.99 billion, down 13.9% year-over-year from ₩75.48 billion in Q1 2024.

• Net income for Q1 2025 was ₩13.26 billion, a 16.9% decrease from ₩15.97 billion in Q1 2024.

• Gross margin declined as gross profit fell to ₩33.39 billion from ₩42.52 billion year-over-year.

Financial highlights

• 2024 revenue reached KRW 407.8 billion, up from KRW 393.2 billion in 2023.

• Operating income for 2024 was KRW 98.5 billion, down from KRW 138.3 billion in 2023.

• Net income for 2024 was KRW 72.4 billion, compared to KRW 96.5 billion in 2023.

• Total assets as of March 31, 2025, were ₩753.09 billion, up from ₩737.31 billion at December 31, 2024.

• Basic and diluted EPS for Q1 2025 was ₩1,538, down from ₩1,852 in Q1 2024.

Outlook and guidance

• Targets global top 3 position by 2031, focusing on advanced markets and economies of scale.

• Plans for 20% annual sales growth through 2030, driven by digital dentistry and new product launches.

• No explicit forward-looking guidance provided, but management notes ongoing review of accounting standards and risk management practices.